These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1453214)

  • 21. Suramin awakes?
    Pinedo HM; van Rijswijk RE
    J Clin Oncol; 1992 Jun; 10(6):875-7. PubMed ID: 1588368
    [No Abstract]   [Full Text] [Related]  

  • 22. [Suramin: pharmacology and antitumor effectiveness of an old parasiticide].
    Rebollo J
    Med Clin (Barc); 1994 Mar; 102(8):301-5. PubMed ID: 8170229
    [No Abstract]   [Full Text] [Related]  

  • 23. Morphohistochemical characterization of suramin--induced chronic toxicity in rat kidney.
    Soldani P; Danesi R; Ricciardi MP; Pellegrini A; Natale G; Paparelli A
    In Vivo; 1992; 6(6):617-20. PubMed ID: 1296811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.
    Small EJ; Halabi S; Ratain MJ; Rosner G; Stadler W; Palchak D; Marshall E; Rago R; Hars V; Wilding G; Petrylak D; Vogelzang NJ
    J Clin Oncol; 2002 Aug; 20(16):3369-75. PubMed ID: 12177096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suramin-induced skin reactions.
    O'Donnell BP; Dawson NA; Weiss RB; Myers CE; James WD
    Arch Dermatol; 1992 Jan; 128(1):75-9. PubMed ID: 1531404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suramin: rapid loading and weekly maintenance regimens for cancer patients.
    van Rijswijk RE; van Loenen AC; Wagstaff J; Meijer E; Lopez R; van Groeningen CJ; Heimans JJ; Pinedo HM
    J Clin Oncol; 1992 Nov; 10(11):1788-94. PubMed ID: 1403059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperendemic West African trypanosomiasis in a rural hospital setting.
    Weir AB; Agbowu J; Ajayi N
    J Trop Med Hyg; 1985 Oct; 88(5):307-11. PubMed ID: 3836307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suramin: prototype of a new generation of antitumor compounds.
    La Rocca RV; Stein CA; Myers CE
    Cancer Cells; 1990 Apr; 2(4):106-15. PubMed ID: 2202382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
    Ord JJ; Streeter E; Jones A; Le Monnier K; Cranston D; Crew J; Joel SP; Rogers MA; Banks RE; Roberts IS; Harris AL
    Br J Cancer; 2005 Jun; 92(12):2140-7. PubMed ID: 15928663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of onchocerciasis in hyperendemic communities in West Africa with small, gradually increasing doses of suramin. 1. Parasitological results and ophthalmological surveillance in a region where transmission has not been interrupted].
    Rougemont A; Thylefors B; Ducam M; Prost A; Ranque P; Delmont J
    Bull World Health Organ; 1980; 58(6):917-22. PubMed ID: 6971188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of metastatic adrenal carcinoma with suramin].
    Allolio B; Jaursch-Hancke C; Reincke M; Arlt W; Metzler U; Winkelmann W
    Dtsch Med Wochenschr; 1989 Mar; 114(10):381-4. PubMed ID: 2924693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials referral resource. Prostate cancer II.
    Cheson BD; Phillips PH; Kaplan RS
    Oncology (Williston Park); 1995 Jan; 9(1):50, 55. PubMed ID: 7718441
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.
    Hutson PR; Tutsch KD; Rago R; Arzoomanian R; Alberti D; Pomplun M; Church D; Marnocha R; Cheng AL; Kehrli N; Wilding G
    Clin Cancer Res; 1998 Jun; 4(6):1429-36. PubMed ID: 9626459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative complications in patients receiving suramin therapy.
    Cole DJ; Ettinghausen SE; Pass HI; Danforth DN; Linehan MW; Myers CW; Cooper MR; Sindelar WF
    Surgery; 1994 Jul; 116(1):90-5. PubMed ID: 8023275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent research on the biological activity of suramin.
    Voogd TE; Vansterkenburg EL; Wilting J; Janssen LH
    Pharmacol Rev; 1993 Jun; 45(2):177-203. PubMed ID: 8396782
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
    Dawson N; Figg WD; Brawley OW; Bergan R; Cooper MR; Senderowicz A; Headlee D; Steinberg SM; Sutherland M; Patronas N; Sausville E; Linehan WM; Reed E; Sartor O
    Clin Cancer Res; 1998 Jan; 4(1):37-44. PubMed ID: 9516950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of the administration of suramin treatment after muscle injury.
    Nozaki M; Ota S; Terada S; Li Y; Uehara K; Gharaibeh B; Fu FH; Huard J
    Muscle Nerve; 2012 Jul; 46(1):70-9. PubMed ID: 22644812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of adaptive control with feedback to individualize suramin dosing.
    Scher HI; Jodrell DI; Iversen JM; Curley T; Tong W; Egorin MJ; Forrest A
    Cancer Res; 1992 Jan; 52(1):64-70. PubMed ID: 1727387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of onchocerciasis with low, increasing doses of suramin in hyperendemic communities of Western Africa: 2. Clinical parasitologic and ophthalmologic results in a zone where transmission is controlled].
    Rougemont A; Hien M; Thylefors B; Prost A; Rolland A
    Bull World Health Organ; 1984; 62(2):261-9. PubMed ID: 6610495
    [No Abstract]   [Full Text] [Related]  

  • 40. [Filtering glaucoma operations. Can growth factor blockers replace antimetabolites?].
    Mietz H
    Ophthalmologe; 1997 Mar; 94(3):242-7. PubMed ID: 9181845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.